XVII International AIDS Conference in Mexico City. Jeffrey Sturchio, Vice President of Merck & Co, talks about the development of protease inhibitors in 1996 and the relationship between the activists and the drug industry.

XVII International AIDS Conference in Mexico City. Jeffrey Sturchio, Vice President of Merck & Co, talks about the development of protease inhibitors in 1996 and the relationship between the activists and the drug industry.

Geoffrey Schild, Virologist and Director of the National Institute for Biological Standards and Control (NIBSC), talks about the Swedish contributions to AIDS research and collaboration with funding agencies such as Nutek, and reflects on HIV vaccines.